- 18-19.03.2024
- מתחם אקספו, תל אביב
תכנית הכנס השנתי
| שעה | שם ההרצאה |
|---|---|
| 07:30-08:30 | התכנסות |
| 08:30-08:45 | דברי פתיחה דר' שחר שלי ויו"ר פורום האחיות הנוירולוגי הארצי, דימה רוזנפלד ויעל ספרן |
| 08:45-09:15 | רמת הכרה – פיזיולוגיה ופתופיזיולוגיה מחמוד אבו חלף, מתאם שבץ מוחי,המרכז הרפואי הלל יפה |
| 09:15-09:45 | פיתוח תפקיד אח.ות מומחים-מחלום למציאות דר' הילה פיגל, מנהלת המחלקה לפיתוח מקצועי, מינהל האֲחָיוּת, משרד הבריאות |
| 09:45-10:05 | שילוב ידיים למען מטופלי השבץ פנינה רוזנצוויג, מנכ"לית עמותת נאמן |
| 10:05-10:40 | חדשנות בטיפול באפילפסיה בחאש מלאק, סגנית אחות אחראית נוירולוגיה שיבא |
| 10:40-11:10 | הפסקת קפה וצפייה בפוסטרים |
| 11:10-11:40 | על כנפי הרוח בעולם הרפואה הגב' הלן זילצר, מנהלת השירות ליווי רוחני, בית החולים ברזילי |
| 11:40-12:10 | גישה רב תחומית למטפלי טרשת נפוצה דר' אופיר זמירה, הלל יפה |
| 12:30-13:15 | ארוחת צהרים |
| 13:15-13:45 | שירות חדש בניהול התנהגות מרחוק לחולים הסובלים מדמנסיה ניסה יוספין,מומחית קלינית בגריאטריה, רמב"ם |
| 13:45-14:00 | סיכום היום בדגש על פתיחת השדה הקליני הנוירולוגי למשתלמים מחו"ל וחשיבות בריאותם דימה רוזנפלד, יו"ר פורום האחיות הנוירולוגי הארצי |
| Time | Hall A | Hall B |
|---|---|---|
| 07:30-08:15 | Gathering and Registration | |
| 08:15-09:30 | Parallel Scientific Sessions | |
| Oral Session 3 – Neuroimmunology | Oral Session 4 – Movements Disorders | |
| Chairs: Amir Dori and Adi Wilf-Yarkoni | Chairs: Nurit Omer and Johnathan Reiner | |
| 08:15-08:25 | WATCHFUL-WAITING APPROACH IN AN INTERNATIONAL CASE SERIES OF PATIENTS WITH MOGAD Adi Wilf-Yarkoni, Nanthaya Tisavipat, Fiona Costello, Yoel Schwartzmann, Mark Hellmann, Assaf Tolkovsky, Itay Lotan, Esther Ganelin-Cohen, Hadas Stiebel-Kalish, Adi Vaknin-Dembinsky, Michael Levy, Sean J. Pittock, Eoin P. Flanagan, John J. Chen | ANALYSIS OF α-SYNUCLEIN SEED AMPLIFICATION ASSAY IN CARRIERS OF GBA AND LRRK2 PATHOGENIC VARIANTS Kyle B. Fraser, Anat Mirelman, Omar S. Mabrouk, Nurit Omer, Luis Concha-Marambio, Tanya Gurevich, Anat Bar-Shira, Mali Gana-Weisz, Orly Goldstein, Avi Orr-Urtreger, Meir Kestenbaum, Jesse M. Cedarbaum, Tien Dam, Julia C. Shirvan, Nir Giladi, Danielle Graham, Roy N. Alcalay, Avner Thaler |
| 08:25-08:35 | PREDICTION OF SILENT ACTIVITY AND DISEASE PROGRESSION IN MS WITH THE USE OF A COMBINATION OF OBJECTIVE BIOMARKERS; SUGGESTIONS FOR BUILDING A RISK-CALCULATOR Panayiota Petrou, Ariel Gingzberg, Nour Yaghmour, Tehila Epstein, Ibrahim Kassis, Dimitrios Karussis | OCULOMETRIC MEASURES AS A TOOL FOR ASSESSMENT OF CLINICAL SYMPTOMS AND SEVERITY OF PARKINSON`S DISEASE Ruth Djaldetti, Liron Franken, Eitan Raveh, Israel Rosset, Rivka Kreitman, Ruth Haimi Djaldetti |
| 08:35-08:45 | PROGNOSTIC RISK FACTORS AND CLINICAL INSIGHTS OF SUSAC`S SYNDROME Lior Fuchs, Ifat Vigiser, Hadar Kolb, Keren Regev, Dinah Zur, Zohar Habot-Wilner, Yahav Oron, Ori Elkayam, Arnon Karni | PARKINSON`S DISEASE, A LONG-TERM SEQUELA OF NEUROGENIC ORTHOSTATIC HYPOTENSION WITH CARDIAC SYMPATHETIC DENERVATION Tsvia Fay-Karmon, Sharon Hassin-Baer, Zehava Shabtai, Ehud Druker, Avshalom Leibowitz, Yehonatan Sharabi |
| 08:45-08:55 | EFFECTS OF REPEATED AUTOLOGOUS MESENCHYMAL STEM CELL TRANSPLANTATION ON COGNITION AND SERUM BIOMARKERS IN PROGRESSIVE MS: INTERIM ANALYSIS OF AN OPEN LABEL EXTENSION TRIAL Panayiota Petrou, Ibrahim Kassis, Nour Yaghmour, Tehila Epstein, Ariel Ginzberg, Dimitrios Karussis | OLFACTORY SNIFFING IS ALTERED IN PATIENTS WITH PARKINSON`S DISEASE Michal Andelman-Gur, Neomi Hezi, Adi Ezra, Gal Pinchasof, Sagit Shushan, Noam Sobel, Tanya Gurevich |
| 08:55-09:05 | INTRAVENOUS IMMUNOGLOBULIN TREATMENT FOR ACUTE ATTACKS IN MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY DISEASE (MOGAD) Itay Lotan, John J. Chen, Yael Hacohen, Omar Abdel-Mannan, Sara Mariotto, Saif Huda, Emily Gibbons, Adi Wilf-Yarkoni, Mark A. Hellmann, Hadas Stiebel-Kalish, Sean J. Pittock, Eoin P. Flanagan, Negar Molazadeh, Monique Anderson, Rebecca Salky, Gabriela Romanow, Patrick Schindler, Ankelien Solveig Duchow, Friedemann Paul, Michael Levy | MILD COGNITIVE IMPAIRMENT AMONG LRRK2 AND GBA1 PATIENTS WITH PARKINSON'S DISEASE Avner Thaler, Vered Livne, Einat Rubinstein, Nurit Omer, Achinoam Socher, Batsheva Cohen, Nir Giladi, Julia C. Shirvan, Jesse M. Cedarbaum, Mali Gana-Weisz, Orly Goldstein, Avi Orr-Urtreger, Roy N. Alcalay, Anat Mirelman |
| 09:05-09:15 | MORTALITY AND CANCER RISK IN PATIENTS WITH MYASTHENIA GRAVIS (MG): A RETROSPECTIVE STUDY Mohamed Khateb, Mai Abu Zant, Alaa Bsoul, Tomer Karny, Ronit Leiba, David Yarnitsky, Shahar Shelly | GENOME SEQUENCING REANALYSIS INCREASES THE DIAGNOSTIC YIELD IN DYSTONIA Avi Fellner, Gurusidheshwar M. Wali, Neil Mahant, Bianca R. Grosz, Melina Ellis, Ramesh K. Narayanan, Karl Ng, Ryan L. Davis, Michel C. Tchan, Katya Kotschet, Dennis Yeow, Laura I. Rudaks, Sue-Faye Siow, Gautam Wali, Con Yiannikas, Matthew Hobbs, Joseph Copty, Michael Geaghan, Paul Darveniza, Christina Liang, Laura Williams, Florence C.F. Chang, Hugo Morales-Briceño, Stephen Tisch, Michael Hayes, Scott Whyte, Sarah Kummerfeld, Marina L. Kennerson, Mark J. Cowley, Victor S.C. Fung, Carolyn M. Sue, Kishore R. Kumar |
| 09:15-09:25 | MULTIPLE CHEST SCAN IN MYASTHENIA GRAVIS- RETROSPECTIVE ANALYSIS Yitzhak Friedman, Adi Wilf Yarkoni | LEVODOPA-CARBIDOPA INTESTINAL GEL FOR ADVANCED PARKINSON'S DISEASE: IMPACT OF LRRK2 AND GBA1 MUTATIONS Avner Thaler, Saar Anis, Penina Ponger, Tsviya Fay-Karmon, Vered Livneh, Achinoam Faust-Socher, Lior Greenbaum, Johnathan Reiner, Ariela Hilel, Hertzel Shabtai, Roy N Alcalay, Ruth Djaldetti, Sharon Hassin-Baer, Adi Ezra, Anat Mirelman, Nir Giladi, Tanya Gurevich |
| 09:30-10:45 | Plenary Session 2: Neurotechnology | |
| Chairs: Nirit Lev and Gal Ifergan | ||
| 09:30-09:55 | Neurotech Ecosystem Ofek Salama | |
| 09:55-10:20 | Neurotechnology in National Security and Defense Alona Barnea | |
| 10:20-10:45 | NeuroTalk: Neurologists and Neurotechnology Gal Ifergane | |
| 10:45-11:15 | Coffee Break, ePoster Viewing & Professional Exhibition | |
| 11:15-12:35 | Parallel Sponsored Sessions | |
| Sponsored Symposia 3 Sponsored by NEOPHARM | Sponsored Symposia 4 Sponsored by PFIZER | |
| Novel approaches to managing Myasthenia Gravis Francesco Saccà, Italy | Gepants in the challenging populations Emily Elefant Asaf Honig | |
| Adapting a new treatment to an old disease Shahar Shelly | Sponsored Symposia 5 Sponsored by DEXCEL | |
| New pharmacological Treatment of Epilepsy in Israel 2024 Felix Benninger | ||
| 12:35-13:20 | Lunch, ePoster Viewing & Professional Exhibition | |
| 13:20-15:00 | Plenary Session 3: Neuroimmunology Sponsored by Roche. No involvement in the content | |
| Chairs: Tamir Ben-Hur and Joab Chapman | ||
| 13:20-13:45 | Advanced biological therapies for resistant myasthenia gravis Mark Helman | |
| 13:45-14:10 | Treating progressive multiple sclerosis: who, when, why Daniel Golan | |
| 14:10-14:35 | A neurological approach to treating neurological complications of systemic immune-mediated disorders Joab Chapman | |
| 14:35-15:00 | Bone marrow transplantation in neuroimmunologic disorders: from basic mechanisms to clinical practice Dimitrios Karussis | |
| 15:00-16:30 | Israel Neurological Association Meeting Followed by wine and refreshments |
| Time | Hall A | Hall B |
|---|---|---|
| 07:30-08:30 | Gathering and Registration | |
| 08:30-09:45 | Parallel Scientific Sessions | |
| Oral Session 1 – General Neurology | Oral Session 2 – Stroke and Cerebrovascular | |
| Chairs: Ophir Keret and Shahar Shelly | Chairs: Rani Barnea and Salo Haratz | |
| 08:30-08:40 | THE EFFECT OF GLP-1 AGONISTS ON IDIOPATHIC INTRACRANIAL HYPERTENSION Nofar Frenkel Manzur, Emily Elefant, Nirit Lev | THE EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANT (DOAC) TREATMENT FOR THE PREVENTION OF CEREBROVASCULAR EVENTS IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS; A POPULATION STUDY Asaf Honig, Ruth Smadar, Gal Ifergane |
| 08:40-08:50 | CEREBROTENDINOUS XANTHOMATOSIS IN THE JEWISH POPULATION: A SINGLE CENTER EXPERIENCE Melanie Shanie Roitman, Lior Greenbaum, Efrat Zohar-Dayan, Bruria Ben-Zeev, Tsvia Fay Karmon, Hofit Cohen, Sharon Hassin-Baer | ACUTE INCIDENTAL CEREBRAL MICROINFARCTS MAY PREDICT ISCHEMIC STROKE IN CANCER PATIENTS Jonathan Naftali, Rani Barnea, Ruth Eliahou, Keshet Pardo, Assaf Tolkovsky, Vadim Hasminski, Walid Saliba, Sivan Bloch, Avi Leader, Eitan Auriel |
| 08:50-09:00 | DETERMINANTS OF DEMENTIA PHENOTYPE IN ISRAELIS OF NORTHERN AFRICAN & MIDDLE EASTERN DESCENT- THE DIASPORA STUDY Ophir Keret, Felix Beninnger, Ilan Goldberg, Dan Biderko, Amir Glik | EFFICACY AND SAFETY OF APIXABAN IN THE TREATMENT OF CEREBRAL VENOUS SINUS THROMBOSIS: A MULTI-CENTRE STUDY Naaem Simaan, Hen Hallevi, Asaf Honig, Issa Metanis, Rom Mendel, Rani Barnea, Eitan Auriel, Jonathan Naftali, Shorooq Aladdin, David Orion, Ronen Leker, Jeremy Molad |
| 09:00-09:10 | IMAGING BLOOD BRAIN BARRIER DYSFUNCTION IN DRUG RESISTANCE EPILEPSY: A MULTI-CENTER FEASIBILITY STUDY Nir Cafri, Daniel Zarhin, Ilya Urman, Ben Whatley, Mark Maclean, Laith Alhadid, Lyna Kamintsky, Sheida Mirlo, Alon Friedman, Felix Beninger | ARTERIAL FLOATING MURAL THROMBI ARE A CHARACTERISTIC IMAGING PATTERN IN SARS-CoV-2-RELATED ISCHEMIC STROKE Keshet Pardo, Omer Har-Noff, Rani Barnea, Jonathan Naftali, Gilad Keinan, Eitan Auriel, Shlomi Peretz |
| 09:10-09:20 | LESSONS LEARNT FROM A LARGE ALS CLINIC DATABASE AT TLVMC Vivian Drory, Yahel Cohen, Nancy Sarah Yacovzada, Nurit Birman, Eran Hornstein, Beatrice Abramovich | CT PERFUSION IMAGING AS PROGNOSTIC FACTOR FOR OUTCOME OF LACUNAR STROKE Stefan Mausbach, Lamya Ahmad Abdallah, Eliel Ben-David, Michael Teitcher, Natan M. Bornstein, Roni Eichel |
| 09:20-09:30 | CRITICAL ILLNESS MYOPATHY: PROGNOSTICATION AND PATHOLOGICAL CORRELATION Shahar Shelly, Pannathat Soontrapa, Nicolas N Madigan, Michael J. Polzin, Tarun D. Singh, Sri Raghav Sista, Pritikanta Paul, Andrea J. Boon, William J. Litchy, Margherita Milone, Teerin Liewluck | CT-PERFUSION IS BENEFICIAL FOR THE PREDICTION OF HEMORRHAGIC TRANSFORMATION AFTER THROMBOLYSIS Aviva Alpernas, Hen Hallevi, Udi Sadeh, Tali Jonas-Kimchi, Einor Ben-Assayag, Issa Metanis, Jose Cohen, Ronen Leker, Jeremy Molad |
| 09:30-09:40 | ASSOCIATION BETWEEN GUILLAIN-BARRE SYNDROME AND COVID-19 INFECTION AND VACCINATION: A POPULATION-BASED NESTED CASE-CONTROL STUDY Haya Bishara, Anat Arbel, Ofra Barnett-Griness, Sivan Bloch, Walid Saliba | DIAGNOSTIC YIELD OF HIGH RESOLUTION VESSEL WALL MAGNETIC RESONANCE IMAGING IN THE EVALUATION OF STROKE IN THE YOUNG Tamer Jubeh, Naem Simaan, Fatma Shalabi, Hamzeh Joubran, Issa Metanis, Yoav Pereg, Yoel Shwartzman, Jad Magadella, Moshe Gomori, Jose Cohen, Ronen Leker |
| 09:45-10:15 | Coffee Break, ePoster Viewing & Professional Exhibition | |
| 10:15-12:30 | Plenary Session 1: European Academy of Neurology – Israel Neurological Association | |
| Chairs: David Tanne and Nirit Lev | ||
| Keynote Neuroscience Lecture Brain health is tightly dependent on the health of the immune system: Boosting immunity to defeat aging and age-related dementia Michal Schwartz | ||
| Greetings Isaac Herzog, President of the State of Israel Sefi Mendelovich, Deputy Director General of the Ministry of Health Pnina Rosenzweig, CEO at Neeman, Stroke Survivors Organization | ||
| Burden of Neurological Diseases, Brain Health and the EAN Paul Boon, President, European Academy of Neurology | ||
| Neurology in Israel and the Israel Neurological Association perspective David Tanne, President Israel Neurological Association | ||
| What's new in Movement disorders? Olivier Rascol, France | ||
| Discussion | ||
| 12:30-13:30 | Lunch, ePoster Viewing & Professional Exhibition | |
| 13:30-14:45 | Parallel Sponsored Sessions | |
| Sponsored Symposia 1 Sponsored by ABBVIE Symposium | Sponsored Symposia 2 – New Treatments in Neurology Sponsored by EISAI | |
| Chair: Tamir Ben-Hur | ||
| Innovations in Parkinson's disease treatment Ilana Schlesinger | New Treatments for Alzheimer's disease Amir Glik | |
| Progress in Migraine Prevention – A Year of Experience with Gepants Nirit Lev and Oved Daniel | Specialized infrastructure and challenges in administration of new disease modifying therapies in Alzheimer's disease Tamara Shiner | |
| Insomnia and a new DORA treatment Rivi Tauman | ||
| 14:45-16:40 | Parallel Scientific Sessions | |
| Mini-Oral Session 1 | Mini-Oral Session 2 | |
| Chairs: Meir Kestenbaum and Baruch El-Ad | Chairs: Oved Daniel and Radi Shahien | |
| 14:45-14:52 | CT PERFUSION IS A VALUABLE TOOL FOR THE DIAGNOSIS OF NON-CONVULSIVE SEIZURES AND POST-ICTAL STATE Netta Agajany, Elena Tomashpolski, Itzhak Kimiagar, Inna Sagi, Revital Gandelman-Marton, Shlomi Peretz | QUANTITATIVE SONOGRAPHIC ASSESSMENT OF MUSCLE THICKNESS PREDICTS SURVIVAL IN ALS Noga Odess, Vivian Drory, Vera Bril, Alon Abraham |
| 14:52-14:59 | INCREASE IN PLASMA pTau181 LEVELS AND DECREASE OF EXECUTIVE FUNCTIONS IN HEALTHY CARRIERS OF E200K MUTATION Noa Bregman, Tamara Shiner, Yifat Alcalay, Aya Bar-David, Talya Nathan, Mali Gana-Weisz, Orly Goldstein, Tal Glinka, Roy Alcalay, Noa Trablus, Gitit Kave, Nurit Omer | ASSESSING THE APPLICABILITY OF THE 2023 INTERNATIONAL MOGAD PANEL CRITERIA IN REAL-WORLD CLINICAL SETTINGS Ariel Rechtman, Omri Zveik, Lyne Shweiki, Garrick Hoichman, Tal Freidman-Korn, Adi Vaknin-Dembinsky |
| 14:59-15:06 | HYPERBARIC OXYGEN THERAPY IMPROVES NEUROCOGNITIVE FUNCTIONS AND SYMPTOMS OF POST-COVID CONDITION: A RANDOMIZED CONTROLLED TRIAL AND A ONE YEAR LONGITUDINAL FOLLOW- UP Karin Elman Shina | REAL WORD EFFICACY OF CLADRIBINE IN MS USING OBJECTIVE BIOMARKERS: QUANTITATIVE MRI AND SERUM NEUROFILAMENTS Panayiota Petrou, Ibrahim Kassis, Nour Yaghmour, Tehila Epstein, Ariel Gingzberg, Dimitrios Karussis |
| 15:06-15:13 | NEUROLOGICAL IMPACT OF HERPES ENCEPHALITIS: EXPLORING YEARS OF LIFE LOST (YLL) AND PATTERNS OF PREMATURE MORTALITY Mark Katson, Shahar Shelly | TOXIC METALS AND ORGANOPHOSPHATE IN MULTIPLE SCLEROSIS PATIENTS Ayelet Armon Omer, Tarek Mansor, Fadi Shbat, Michael Edelstein, Radi Shahien |
| 15:13-15:20 | ALZHEIMER’S DISEASE SUBJECTS HAVE SMALLER NON-JUGULAR VENOUS DRAINAGE SYSTEM COMPARED TO COGNITIVE NORMAL POPULATION Keshet Pardo, Vadim Khasminsky, Ophir Keret, Felix Benninger, Ilan Goldberg, Eitan Auriel, Amir Glik | ASSOCIATION BETWEEN CLINICAL CHARACTERISTICS, ACUTE STEROID TREATMENT AND OLIGOCLONAL BANDS RESULTS IN MULTIPLE SCLEROSIS: A RETROSPECTIVE STUDY Assaf Tolkovsky, Keshet Pardo, Mark Hellmann, Itay Lotan, Adi Wilf-Yarkoni |
| 15:20-15:27 | PRIMARY INTRACRANIAL HEMORRHAGE: CHARACTERISTICS, DISTRIBUTION, RISK FACTOR, AND OUTCOMES A COMPARATIVE STUDY BETWEEN TWO ETHNIC GROUPS IN NORTHERN ISRAEL Jamal Saad, Chen Hanna Ryder, Mahmod Hasan, Galina Keigler, Samih Badarny | VENUS OPACIFICATION POST MCA THROMBECTOMY – A MARKER FOR GOOD CLINICAL OUTCOME Keshet Pardo, Liron Snapir, Rani Barnea, Ahmad Atamna, Alain Perlow, Ran Brauner, Guy Raphaeli, Eitan Auriel, Michael Findler |
| 15:27-15:34 | EVALUATING GPT-4 AS A CLINICAL DECISION SUPPORT TOOL IN ISCHEMIC STROKE MANAGEMENT Amit Haim Shmilovitch, Mark Katson, Michal Cohen-Shelly, Shlomi Pertz, Dvir Aran, Shahar Shelly | REAL WORD EFFICACY OF OCRELIZUMAB TREATMENT IN MULTIPLE SCLEROSIS PATIENTS USING OBJECTIVE BIOMARKERS: QUANTITATIVE MRI AND SERUM NEUROFILAMENT LEVELS Panayiota Petrou, Ibrahim Kassis, Nour Yaghmour, Tehila Epstein, Ariel Gingzberg, Dimitrios Karussis |
| 15:34-15:41 | ACUTE INCIDENTAL CEREBRAL MICROINFARCTS ARE COMMON IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME Jonathan Naftali , Rani Barnea, Ruth Eliahou, Walid Saliba, Sivan Bloch, Avi Leader, Eitan Auriel | IMPROVING WORK UP AMONGST PATIENTS WITH RARE MOVEMENT DISORDERS ACCORDING TO DIAGNOSTIC YIELD FINDINGS– UPDATE FROM SINGLE CENTER NEUROGENETIC CLINIC Dvir Penn, Yam Amir, Gil Ben David, Hagit Baris Feldman, Yuval Yaron, Tanya Gurevich, Roy Alcalay, Penina Ponger |
| 15:41-15:48 | DEMOGRAPHIC FACTORS AFFECTING IN-HOSPITAL DELAY IN ACUTE STROKE TREATMENT: RETROSPECTIVE STUDY Jonathan Naftali, Gal Tsur, Eitan Auriel, Guy Rephaeli, Michael Findler, Ran Brauner, Alain Perlow, Ophir Keret, Rani Barnea | THE EFFICACY OF OPTOGENETIC MEDIATED INHIBITION OF THE SUB-THALAMIC NUCLEUS OR GLOBUS PALLIDUS INTERNUS IN ALLEVIATING MOTOR SYMPTOMES IN EXPERIMENTAL PARKINSON DISEASE (MOUSE-MODEL) Shani Sobol, Jackie Schiller, Yitzhak Schiller |
| 15:48-15:55 | CHARACTERISTICS OF PATIENTS WITH CEREBRAL SINUS VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME: A MULTI-CENTER STUDY Naaem Simaan, Hen Hallevi, Asaf Honig, Issa Metanis, Ron Mendel, Rani Barnea, Eitan Auriel, Jonathan Naftali, Shorooq Aladdin, David Orion, Aviva Alpernas, Ilya Kirgner, David Varon, Ronen Leker, Jeremy Molad | CHECKPOINT INHIBITORS – A DOUBLE EDGED SWORD Maor Mermelstein, Alexandra Amiel, Adi Wilf-Yarkoni, Shlomit Katz-Yust |
| 15:55-16:02 | UTILIZING INFLAMMATORY BIOMARKERS AND CLOT SOURCE IN ISCHEMIC STROKE Lamis Qassim, Nitai Weinberg, Joab Chapman, Zeev Itsekson-Hayosh, Efrat Shavit-Stein | DIRECTED FUNCTIONAL CONNECTIVITY OF THE DEFAULT-MODE-NETWORK OF YOUNG AND OLDER HEALTHY SUBJECTS Gadi Goelman, Rotem Dan, Ondrej Bezdicek, Robert Jech, Dana Ekstein |
| 16:02-16:09 | CCR5-Δ32 POLYMORPHISM – A POSSIBLE PROTECTIVE FACTOR FOR POST-STROKE PTSD SYMPTOMS Einor Ben Assayag, Oren Tene, Jeremy Molad, Aviva Alpernas, Hen Hallevi | BRAIN MRI CLASSIFICATION MODEL FOR IDENTIFYING CHRONIC HEADACHE POST MILD TBI Sivan Attias, Roni Ramon Gonen, Yaara Erez, Noam Bosak, David Yarnitsky, Shahar Shelly |
| 16:09-16:16 | PREDICTORS OF ACUTE SYMPTOMATIC SEIZURE IN CEREBRAL VENOUS THROMBOSIS PATIENTS – A MULTICENTER COHORT STUDY Naaem Simman, Ronen Leker, Hen Halevi, Rani Barnea, Eitan Auriel, Shlomi Peretz, David Orion, Shorooq Aladin, Rom Mendel, Jeremy Molad, Asaf Honig | THYROID HORMONE DYSFUNCTION IS ASSOCIATED WITH A MORE SEVERE COURSE IN DEMYELINATING DISEASES Tal Friedman Korn, Ariel Rechtman, Omri Zveik, Nitsan Haham, Livnat Brill, Adi Vaknin-Dembinsky |
| 16:16-16:23 | COMPARISON BETWEEN MOYAOYA DISEASE AND MOYAMOYA SYNDROME IN ISRAEL Yoel Schwartzmann, Sergei Spektor, Samuel Moscovici, Hamza Jubran, Issa Metanis, Tamer Jouaba, Jose Cohen, John Moshe Gomori, Ronen Robert Leker | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY SUCCESFULLY TREATED WITH ALLOGENEIC BK VIRUS-SPECIFIC T CELLS Yair Mina, David Hagin, Orna Eisenstein, Yael Paran, Tal Freund, Ronen Ben-Ami, Ron Ram |
| 16:23-16:30 | USE OF SIMULATION-BASED TEAM TRAINING FOR ACUTE NEUROLOGY CRISIS MANAGEMENT: A PARADIGM SHIFT IN MEDICAL EDUCATION FOR NEUROLOGY RESIDENTS Yarden Sela, Mai Cassuto, Tali Capua, Luiza Dadbaeiv, Jeremy Molad, Hen Hallevi, Avi Gadot, Nir Giladi, Estelle Seyman | |
| 16:30-16:40 | BRAIN HEALTH SCREENING IN ISRAEL`S DIVERSE POPULATION Rafi Hadad, Rachel Ben-Hayun, Rawan Ayoub-Agbaria, Nataliya Yarovinsky, Essam Shehadeh, Merav Shor, Michal Levavi, Tali Fisher, Judith Aharon Peretz, David Tanne |
